Brain metastases of lung cancer;Hirnmetastasen beim lungenkarzinom

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 4, 2006, Pages 165-171

  Binder, Daniel ^a   Temmesfeld Wollbruck B ^a   Wurm, R ^a   Woiciechowsky, C ^a   Schaper C ^a   Schurmann D ^a   Suttorp, N ^a   Beinert, T ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Klinik Wartenberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DEXAMETHASONE; ETIRACETAM; ETOPOSIDE; FOTEMUSTINE; GABAPENTIN; GEMCITABINE; LAMOTRIGINE; MISONIDAZOLE; MITOMYCIN; NAVELBINE; PACLITAXEL; PHENYTOIN; TEMOZOLOMIDE; TENIPOSIDE; TOPIRAMATE; VALPROIC ACID; VINCRISTINE; VINDESINE;

BRAIN EDEMA; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOSURGERY; REVIEW; STEREOTAXIC SURGERY;

ANTICONVULSANTS; BRAIN NEOPLASMS; EDEMA; HUMANS; INCIDENCE; LUNG NEOPLASMS; NEOPLASM METASTASIS; PALLIATIVE CARE; PROGNOSIS;

EID: 32044446247     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924941     Document Type: Review

References (53)

1. Agboola O, Benoit B, Cross P et al. Prognostic factors derived from recursive partition analysis (RPA) of radiation therapy oncology group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 1998; 42: 155-159
2. Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363: 1665-1672
3. Antonadou D, Paraskevaidis M, Sarris G et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002; 20: 3644-3650
4. Aoyama H, Shirato H, Nakagawa K, Tago M. Interim report of the JROSG-99-1 multi-institutional randomized trial, comparing radiosurgery alone vs. radiosurgery plus whole brain irradiation for 1-4 metastases (Presentation data). Proc ASCO 2004; 23: 108
5. Arbit E, Wronski M, Burt M, Galicich JH. The treatment of patients with recurrent brain metastases - A retrospective analysis of 109 patients with nonsmall cell lung cancer. Cancer 1995; 76: 765-773
6. Barker FG. Craniotomy for the resection of metastatic brain tumors in the US, 1988-2000. Cancer 2004; 100: 999-1007
7. van den Bent MJ. The role of chemotherapy in brain metastases. Eur J Cancer 2003; 39: 2214-2220
8. Bezjak A, Adam J, Barton R et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002; 38: 487-496
9. Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg 1993; 79: 210-216
10. Bindal AK, Bindal RK, Hess KR et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 1996; 84: 748-754
11. Bonnette P, Puyo P, Gabriel C et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 2001; 119: 1469-1475
12. Bunn PA, Witta SE, Kavanagh B. Brain metastases in small cell lung cancer - The Quan/Videtic/Suh article reviewed. Oncology (Huntingt) 2004; 18: 974-979
13. Chen C, Gaspar LE. Brain metastases in small cell lung cancer - The Quan/Videtic/Suh article reviewed. Oncology (Huntingt) 2004; 18: 980-887
14. Cortes J, Rodriguez J, Aramendia JM et al. Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer. Oncology 2003; 64: 28-35
15. Cotto C, Berille J, Souquet PJ et al. A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer. Eur J Cancer 1996; 32A: 69-71
16. French LA, Galicich JH. The use of steroids for control of cerebral edema. Clin Neurosurg 1964; 10: 212-223
17. Furuse K, Kamimori T, Kawahara M et al. A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis. Br J Cancer 1997; 75: 614-618
18. Gaspar L, Scott C, Rotman M et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745-751
19. Glantz MJ, Cole BF, Forsyth PA et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54: 1886-1893
20. Guerrieri M, Wong K, Ryan G et al. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. Lung Cancer 2004; 46: 107-111
21. Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch C-M. Metaanalyse zum Stellenwert der Positronen-Emissionstomographie mit F-18-Fluorodesoxyglukose (PDG-PET) bei Lungentumoren. Pneumologie 2001; 55: 367-377
22. Herth FJF, Eberhardt R. Screeningprogramme für das Bronchialkarzinom - Contra. Dtsch Med Wochenschr 2005; 130: 467
23. Kelly K, Jr. Bunn PA. Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer? Lung Cancer 1998; 20: 85-91
24. Korfel A, Oehm C, von Pawel J et al. Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation: a multicentre phase II study. Eur J Cancer 2002; 38: 1724-1729
25. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991; 20: 53-58S>
26. Kristjansen PE, Soelberg Sorensen P, Skov Hansen M, Hansen HH. Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidru regimen. Ann Oncol 1993; 4: 579-583
27. Lagerwaard FJ, Levendag PC, Nowak PJCM, Eijkenboom WMH, Hanssens PEJ, Schmitz PIM. Identification of prognostic factors in patients with brain metastases: A review of 1292 patients. Int J Radiat Oncol Biol Phys 1999; 43: 795-803
28. Langer CJ, Mehta MP. Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005; 23: 6207-6219
29. Minotti V, Crino L, Meacci ML et al. Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer. Lung Cancer 1998; 20: 93-98
30. Mintz AH, Kestle J, Rathbone MP et al. A Randomized Trial to Assess the Efficacy of Surgery in Addition to Radioctherapy in Patients with a Single Cerebral Metastasis. Cancer 1996; 78: 1470-1476
31. Muacevic A, Kreth FW, Horstmann GA et al. Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 1999; 91: 35-43
32. Murray KJ, Scott C, Greenberg HM et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997; 39: 571-574
33. O'Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O'Fallon JR. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003; 55: 1169-1176
34. Patchell RA, Tibbs PA, Walsh JW et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494-500
35. Patchell RA, Tibbs PA, Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain - A randomized trial. JAMA 1998; 280: 1485-1489
36. Pfister DG, Johnson DH, Azzoli CG et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22: 330-353
37. Postmus PE, Haaxma-Reiche H, Smit EF et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy - a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 2000; 18: 3400-3408
38. Quan AL, Videtic GMM, Suh JH. Brain metastases in small cell lung cancer. Oncology (Huntingt) 2004; 18: 961-972
39. Sawaya R, Ligon BL, Bindal AK, Bindal RK, Hess KR. Surgical treatment of metastatic brain tumors. J Neurooncol 1996; 27: 269-277
40. Schmidt B, Liebers U, Witt C. Screeningprogramme für das Bronchialkarzinom - Pro. Dtsch Med Wochenschr 2005; 130: 466
41. Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A. Incidence of Brain Metastases in a Cohort of Patients with Carcinoma of the Breast, Colon, Kidney, and Lung and Melanoma. Cancer 2002; 94: 2698-2705
42. Serizawa T, Ono J, Iichi T et al. Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma. J Neurosurg 2002; 97: 484-488
43. Seute T, Leffers P, ten Velde GP, Twijnstra A. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 2004; 100: 801-806
44. Shaw E, Scott C, Souhami L et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000; 47: 291-298
45. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 2002; 97: 1276-1281
46. Simon GR, Wagner H. American College of Chest Physicians: Small cell lung cancer. Chest 2003; 123: 259S-271S(Suppl 1
47. Sneed PK, Suh JH, Goetsch SJ et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002; 53: 519-526
48. Thoas M, Gatzemeier U, Goerg R et al. Empfehlungen zur Diagnostik des Bronchialkarzinoms. Pneumologie 2000; 54: 361-371
49. Twelves CJ, Souhami RL, Harper PG et al. The response of cerebral metastases in small cell lung cancer to systemic chemotherapy. Br J Cancer 1990; 61: 147-150
50. Vecht CJ, Haaxma-Reiche H, Noordijk EM et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33: 583-590
51. Verger E, Gil M, Yaya R et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 2005; 61: 185-191
52. Wong WW, Schild SE, Sawyer TE, Shaw EG. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 1996; 34: 585-590
53. Yokoi K, Kamiya N, Matsuguma H et al. Detection of brain metastasis in potentially operable non-small cell lung cancer - A comparison of CT and MRI. Chest 1999; 115: 714-719